These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy. Palma D; Pickles T Cancer; 2008 May; 112(10):2322-3; author reply 2323. PubMed ID: 18327816 [No Abstract] [Full Text] [Related]
8. [Diagnosis and treatment of prostate cancer]. Auvert J Ann Urol (Paris); 1999; 33(4):259-62. PubMed ID: 10510707 [No Abstract] [Full Text] [Related]
9. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? Messing EM J Urol; 2003 Nov; 170(5):1955; author reply 1955-6. PubMed ID: 14532828 [No Abstract] [Full Text] [Related]
10. Facing the challenge of prostate cancer: the family physician's perspective. Patient perspective #2. Duval J Can J Oncol; 1994 Nov; 4 Suppl 1():15-6; discussion 17. PubMed ID: 8853483 [No Abstract] [Full Text] [Related]
12. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals. Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106 [TBL] [Abstract][Full Text] [Related]
13. [LHRH analogues for the treatment of prostate cancer: an evidence level-based analysis]. Pfitzenmaier J; Altwein JE Aktuelle Urol; 2009 Mar; 40(2):100-8. PubMed ID: 19253209 [TBL] [Abstract][Full Text] [Related]
14. Combined androgen blockade in the management of advanced prostate cancer: a sensible or ostensible approach. Ansari MS; Gupta NP; Hemal AK; Dogra PN; Seth A Int J Urol; 2004 Dec; 11(12):1092-6. PubMed ID: 15663681 [TBL] [Abstract][Full Text] [Related]
15. Improving outcomes in early prostate cancer: Part I--adjuvant treatment. Mazhar D; Ngan S; Waxman J BJU Int; 2006 Oct; 98(4):725-30. PubMed ID: 16978266 [No Abstract] [Full Text] [Related]
16. Early or delayed hormonal therapy in N+ M+ disease. Newling DW Curr Probl Cancer; 2003; 27(1):49-52. PubMed ID: 12569351 [No Abstract] [Full Text] [Related]
17. Re: Additional treatment for pT3 prostate cancer: now, later or never. Pitts WR BJU Int; 2008 Jul; 102(1):133; author reply 133-4. PubMed ID: 18564235 [No Abstract] [Full Text] [Related]